Dissemin is shutting down on January 1st, 2025

Published in

American Heart Association, Arteriosclerosis, Thrombosis, and Vascular Biology, 2(23), p. 198-203, 2003

DOI: 10.1161/01.atv.0000053846.71621.93

Links

Tools

Export citation

Search in Google Scholar

Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells

Journal article published in 2002 by Elena Rabkin, Tommaso Simoncini ORCID, James K. Liao
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Objective— Nontranscriptional signaling mechanisms mediate some of the biological effects of estrogen, such as the rapid actions on the blood vessels. By interacting with phosphatidylinositol 3-kinase (PI3K), estrogen receptor (ER) α leads to activation of protein kinase Akt and to subsequent increase in endothelial nitric oxide synthase activity. Because PI3K is mainly a cytoplasmic complex, we studied the cellular site of interaction between this enzyme and ERα, and we dissected the molecular mechanisms that mediate this interaction. Methods and Results— By using cultured human saphenous vain endothelial cells, we found that cell membrane–bound ERα colocalizes with PI3K and may be responsible for PI3K activation. Furthermore, we characterized the subsequent steps in the activation of the PI3K/Akt signaling cascade, comparing the molecular events that follow insulin or estradiol activation of PI3K. Conclusions— We provide novel evidence for an important role of nonnuclear estrogen receptor in rapid, nontranscriptional responses of human endothelial cells to estrogen.